These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 32805070)

  • 21. Developmental hemostasis: age-specific differences in the levels of hemostatic proteins.
    Attard C; van der Straaten T; Karlaftis V; Monagle P; Ignjatovic V
    J Thromb Haemost; 2013 Oct; 11(10):1850-4. PubMed ID: 23927605
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anti-A/B antibody depletion by semiselective versus ABO blood group-specific immunoadsorption.
    Wahrmann M; Schiemann M; Marinova L; Körmöczi GF; Derfler K; Fehr T; Stussi G; Böhmig GA
    Nephrol Dial Transplant; 2012 May; 27(5):2122-9. PubMed ID: 22086972
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Reuse of Immunoadsorption Columns in ABO-Incompatible Kidney Transplantation Is Efficient: The Swiss Experience.
    Schiesser M; Steinemann DC; Hadaya K; Huynh-Do U; Eisenberger U; Binet I; Fehr T; Dickenmann M
    Transplantation; 2015 May; 99(5):1030-5. PubMed ID: 25340594
    [TBL] [Abstract][Full Text] [Related]  

  • 24. ABO-incompatible live donor renal transplantation using blood group A/B carbohydrate antigen immunoadsorption and anti-CD20 antibody treatment.
    Nordén G; Briggs D; Cockwell P; Lipkin G; Mjörnstedt L; Mölne J; Ready A; Rydberg L; Samuelsson O; Svalander CT; Breimer ME
    Xenotransplantation; 2006 Mar; 13(2):148-53. PubMed ID: 16623810
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of different apheresis modalities on coagulation factor XIII level during antibody removal in ABO-blood type incompatible living related renal transplantation.
    Hanafusa N; Hamasaki Y; Kawarasaki H; Kido R; Shibagaki Y; Ishikawa A; Enomoto Y; Fujita T; Noiri E; Nangaku M
    Transfus Apher Sci; 2013 Oct; 49(2):254-8. PubMed ID: 23827327
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association of genetic variants of hemostatic genes with myocardial infarction in Egyptian patients.
    El-Fattah AAA; Sadik NAH; Sedrak H; Battah A; Nabil M
    Gene; 2018 Jan; 641():212-219. PubMed ID: 29054763
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Removal of lymphocytotoxic antibodies by pretransplant immunoadsorption therapy in highly sensitized renal transplant recipients.
    Kupin WL; Venkat KK; Hayashi H; Mozes MF; Oh HK; Watt R
    Transplantation; 1991 Feb; 51(2):324-9. PubMed ID: 1994523
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Selective plasma exchange can reduce auto-antibodies in patients with bullous pemphigoid without affecting factor XIII and fibrinogen.
    Nasu K; Hanafusa N; Nangaku M
    J Clin Apher; 2017 Dec; 32(6):589-591. PubMed ID: 27709645
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Perioperative course of FXIII in children undergoing major surgery.
    Haas T; Korte W; Spielmann N; Mauch J; Madjdpour C; Schmugge M; Weiss M
    Paediatr Anaesth; 2012 Jul; 22(7):641-6. PubMed ID: 21933302
    [TBL] [Abstract][Full Text] [Related]  

  • 30. ABO-incompatible living-donor kidney transplantation in children.
    Shishido S; Asanuma H; Tajima E; Hoshinaga K; Ogawa O; Hasegawa A; Honda M; Nakai H
    Transplantation; 2001 Sep; 72(6):1037-42. PubMed ID: 11579297
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Elevated fibrinogen, von Willebrand factor, and Factor VIII confer resistance to dilutional coagulopathy and activated protein C in normal pregnant women.
    Tanaka KA; Bharadwaj S; Hasan S; Judd M; Abuelkasem E; Henderson RA; Chow JH; Williams B; Mazzeffi MA; Crimmins SD; Malinow AM
    Br J Anaesth; 2019 Jun; 122(6):751-759. PubMed ID: 30916034
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High-dose Factor XIII administration induces effective hemostasis for trauma-associated coagulopathy (TAC) both in vitro and in rat hemorrhagic shock in vivo models.
    Nagashima F; Inoue S; Koami H; Miike T; Sakamoto Y; Kai K
    J Trauma Acute Care Surg; 2018 Sep; 85(3):588-597. PubMed ID: 29851904
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Post-Transplantation Immunoadsorption Can Be Withheld in ABO-Incompatible Kidney Transplant Recipients.
    de Weerd AE; van Agteren M; Ijzermans JN; Weimar W; Betjes MG
    Ther Apher Dial; 2015 Oct; 19(5):513-7. PubMed ID: 26219347
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antigen-Specific versus Non-Antigen-Specific Immunoadsorption in ABO-Incompatible Renal Transplantation.
    Thölking G; Koch R; Pavenstädt H; Schuette-Nuetgen K; Busch V; Wolters H; Kelsch R; Reuter S; Suwelack B
    PLoS One; 2015; 10(6):e0131465. PubMed ID: 26121389
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hemostatic factors in the Coronary Artery Risk Development in Young Adults (CARDIA) Study.
    Green D; Ruth KJ; Folsom AR; Liu K
    Arterioscler Thromb; 1994 May; 14(5):686-93. PubMed ID: 8172846
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clotting factor XIII and desmopressin improve hemostasis in uncontrolled bleeding.
    Carreiro PR; Rezende-Neto JB; Lisboa Tde A; Ribeiro DD; Camargos ER; Andrade MV; Rizoli SB; Melo JR
    Acta Cir Bras; 2015 Mar; 30(3):170-7. PubMed ID: 25790004
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Non-autoimmune combined factor XIII A and B subunit deficiencies in rheumatoid arthritis patients treated with anti-interleukin-6 receptor monoclonal antibody (tocilizumab).
    Souri M; Mokuda S; Inanami H; Osaki T; Takasugi K; Ichinose A
    Thromb Res; 2016 Apr; 140():100-105. PubMed ID: 26938156
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Effect of Ex Vivo Factor XIII Supplementation on Clot Formation in Blood Samples From Cardiac and Scoliosis Surgery Patients.
    Shams Hakimi C; Carling MS; Hansson EC; Brisby H; Hesse C; Radulovic V; Jeppsson A
    Clin Appl Thromb Hemost; 2018 May; 24(4):677-683. PubMed ID: 28651441
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quality of Clotting Factor Activity in Fresh Frozen Plasma at Thaw with a Microwave System and after Storage at 4 degrees C for 48 Hours.
    Kuta P; Hauck-Dlimi B; Strobel J; Zimmermann R; Eckstein R
    Clin Lab; 2016; 62(6):987-91. PubMed ID: 27468559
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Terminal Phase Components of the Clotting Cascade in Patients with End-Stage Renal Disease Undergoing Hemodiafiltration or Hemodialysis Treatment.
    Pénzes K; Hurják B; Katona É; Becs G; Balla J; Muszbek L
    Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33182600
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.